CVE-2019-13546In IntelliSpace Perinatal, Versions K and prior, a vulnerability within the IntelliSpace Perinatal application environment could enable an unauthorized attacker with physical access to a locked appli…
Updated under an hour ago ()
Does this affect you?
It affects philips intellispace_perinatal. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.40%, higher than 33% of scored CVEs.
Do this next
Free account, 1 product
In IntelliSpace Perinatal, Versions K and prior, a vulnerability within the IntelliSpace Perinatal application environment could enable an unauthorized attacker with physical access to a locked application screen, or an authorized remote desktop session host application user to break-out from the containment of the application and access unauthorized resources from the Windows operating system as the limited-access Windows user. Due to potential Windows vulnerabilities, it may be possible for additional attack methods to be used to escalate privileges on the operating system.
- CVSS
- 6.8 MEDIUM (v3.1, NVD)CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-668
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.40% (percentile 33)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Aug 4, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
philips intellispace_perinatal philips:intellispace_perinatal | through k | NVD |
References
- https://www.us-cert.gov/ics/advisories/icsma-19-297-01x-refsource-misc, third-party-advisory, us-government-resource
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.